Image: Kindbody

Fertility clinic network Kindbody is announcing the addition of Kindlabs, a new division to conduct in-house genetic testing, expanding Kindbody’s range of comprehensive services to offer seamless, end-to-end care. The Kindlabs launch follows last year’s acquisition of Phosphorus Labs, a preventative genomics company.

Kindlabs will operate from its state-of-the-art 8,000 square foot laboratory located in Secaucus, New Jersey. It’s headed by Dr. Amber Cooper, Chief Medical Officer of Genomics and Laboratory Sciences at Kindbody, and Manuel Viotti, Ph.D., HCLD, Vice President of Preimplantation Genetic Testing (PGT) and Clinical Laboratory Director.

Dr. Angeline Beltsos, CEO, Clinical, at Kindbody, shares: “At the heart of Kindbody’s mission is to help build healthy families for our patients. The addition of Kindlabs combines industry-leading technology and expertise, and stringent quality standards, to optimize our patients’ chances of achieving a successful pregnancy and bringing home a healthy baby.”

The establishment of Kindlabs integrates genomics into Kindbody’s unique patient care model. The addition boosts the potential of patients achieving successful pregnancies and healthier babies, by leveraging top-tier technology, expert knowledge, and strict quality standards. Kindlabs will provide a full-range genetic testing platform, incorporating wet lab chemistry, software, and bioinformatics. The focus is to offer extensive, medical-grade genetic tests that make genomic information accessible at affordable price points.

To ensure accurate and reliable results, Kindlabs has acquired certification by the Clinical Laboratory Improvement Amendments (CLIA). Furthermore, the division is participating in the accreditation program of the College of American Pathologists (CAP), a benchmark for molecular diagnostics. This marks a significant shift for Kindbody as the company previously outsourced its preimplantation genetic testing.

The leadership team at Kindlabs consists of respected figures in the field. Dr. Cooper is a well-regarded international expert in genomics and ovarian aging, possessing double board certification in obstetrics and gynecology as well as reproductive endocrinology and infertility. She holds academic positions at Wayne State University School of Medicine and St. Louis University, while also being a widely published author on fertility and women’s health topics.

On the other hand, Dr. Viotti, a renowned reproductive molecular geneticist, holds an appointment as a senior scientist at the Zouves Foundation for Reproductive Medicine. His roles extend to being the director of the Preimplantation Genetic Diagnosis International Society (PGDIS), a board member of the American Society for Reproductive Medicine (ASRM) PGT-SIG, and the founder and officer of the International Registry of Mosaic Embryo Transfers (IRMET).

With the launch of Kindlabs, Kindbody aims to cover the full spectrum of reproductive health services. These include both female and male fertility assessments, fertility preservation, in vitro fertilization (IVF), donor and surrogacy services, adoption, as well as physical, mental, and emotional support services.

Show CommentsClose Comments

Leave a comment